48 reports

X-ray films cannot diagnose muscle or tendon injuries. ##.

  • General Medicine And Specialty Medicine
  • Europe
  • World
  • Integra LifeSciences Holdings Corporation
  • Stryker Corporation

You can easily book an appointment with one online.

  • Blood Disease
  • General Medicine And Specialty Medicine
  • World
  • Forecast
  • Merck & Co., Inc.

Healthcare is one of the most regulated industries in the United States.

  • General Medicine And Specialty Medicine
  • United States
  • Medtronic, Inc.
  • NuVasive, Inc.
  • Stryker Corporation

Private Cord Blood Banks PART D: ANNEXURE ##.

  • General Medicine And Specialty Medicine
  • APAC
  • United States
  • World
  • Market Shares

Similarly, the Universities' portfolio in Phase II and Phase I stages comprises ## and ## molecules, respectively.

  • General Medicine And Specialty Medicine
  • Neurological Disorder
  • Therapy
  • Transplantation
  • Shire plc
  • GENE THERAPY FOR HIGH-GRADE GLIOMA AND LIVER TRANSPLANTATION - DRUG PROFILE
  • PRODUCTS UNDER DEVELOPMENT BY UNIVERSITIES/INSTITUTES, H1 2018

Day ##).

  • General Medicine And Specialty Medicine
  • Liver Transplant
  • Therapy
  • United States
  • Product Initiative

The prominent features of this report are - ##.

  • General Medicine And Specialty Medicine
  • Infectious Disease
  • Therapy
  • Transplantation
  • Chimerix, Inc.
  • Official Title
  • Clinical Trial profile. 493 Trial Title

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## ## ## Takeda Pharmaceutical Co Ltd ## ## ## ## ## ## ## ## Incyte Corp ## ## ## ## ## ## ## ## Bellicum Pharmaceuticals Inc ## ##

  • General Medicine And Specialty Medicine
  • Monoclonal Antibody
  • Pharmaceutical
  • United States
  • World
  • GENE THERAPY FOR HIGH-GRADE GLIOMA AND LIVER TRANSPLANTATION - DRUG PROFILE
  • PRODUCTS UNDER DEVELOPMENT BY UNIVERSITIES/INSTITUTES, H2 2018

Day ##).

  • Digestive System Disorder
  • General Medicine And Specialty Medicine
  • Liver Transplant
  • United States
  • Product Initiative

This is the first gene therapy clinical trial of this type for pediatric brain tumors.

  • General Medicine And Specialty Medicine
  • Pharmaceutical
  • United States
  • Company
  • ZIOPHARM Oncology, Inc.

Diseases such as osteoporosis or osteogenesis imperfecta (brittle bones) may require a systemic approach, as might be provided by cell and gene therapy.

  • General Medicine And Specialty Medicine
  • United States
  • Biomet, Inc.
  • DePuy Synthes, Inc.
  • Stryker Corporation

Q. ##.

  • Biotech Diagnostics
  • General Medicine And Specialty Medicine
  • North America
  • United States
  • F. Hoffmann-La Roche Ltd.

GlobalData Cellect Biotechnology Ltd reported one pharmaceuticals & healthcare deal worth $## million in YTD 2018.

  • Biotechnology
  • General Medicine And Specialty Medicine
  • United States
  • Company
  • Cellect Biotechnology Ltd.
  • GENE THERAPY TO ACTIVATE PD-L1 FOR COLITIS AND GRAFT VERSUS HOST DISEASE - DRUG PROFILE
  • GRAFT VERSUS HOST DISEASE (GVHD) - PIPELINE BY ENGENE INC, H2 2018

It also developed a non-viral gene-therapy platform to deliver DNA sequences that encrypt specific therapeutic proteins beyond mucosal barriers. enGene' s proprietary technology platform Gene Pill facilitates oral delivery of gene therapy.

  • General Medicine And Specialty Medicine
  • Healthcare
  • Medical Biotechnology
  • United States
  • Product Initiative
  • GENE THERAPY TO ACTIVATE PD-L1 FOR COLITIS AND GRAFT VERSUS HOST DISEASE - DRUG PROFILE
  • TAKEDA PHARMACEUTICAL CO LTD

This advice follows a pre-Investigational New Drug (pre-IND) meeting, which Cynata recently held with the FDA s Office of Cellular, Tissue and Gene Therapies.

  • Cell Therapy
  • General Medicine And Specialty Medicine
  • Specialty Hospital
  • Transplantation
  • Pluristem Therapeutics Inc.

GlobalData Cellect Biotechnology Ltd, reported one medical equipment deal worth $## million in YTD 2018.

  • General Medicine And Specialty Medicine
  • Medical Equipment
  • United States
  • Company
  • Cellect Biotechnology Ltd.

The prominent features of this report are - ##.

  • Blood Disease
  • General Medicine And Specialty Medicine
  • Therapy
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Lymphoma
  • United States
  • World

ONE UNIT REFERS TO ONE SPECIALTY BED.

  • General Medicine And Specialty Medicine
  • Mattress
  • France
  • Western Europe
  • Market Size
  • GENE THERAPY TO ACTIVATE PD-L1 FOR COLITIS AND GRAFT VERSUS HOST DISEASE - DRUG PROFILE
  • (GVHD)

Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description ENGENE INC NA NA GENE THERAPY TO ACTIVATE PD-L## FOR COLITIS AND GRAFT VERSUS HOST DISEASE - DRUG PROFILE GENE THERAPY TO ACTIVATE PD-L## FOR COLITIS AND GRAFT VERSUS HOST DISEASE

  • General Medicine And Specialty Medicine
  • Healthcare
  • Medical Biotechnology
  • United States
  • Product Initiative

ITB-Med AB (ITBMed) is a biopharmaceutical company that develops specific immunomodulatory biologics for organ and stem cell transplantation and gene therapy.

  • General Medicine And Specialty Medicine
  • Health Services
  • Therapy
  • United States
  • Product Initiative

One unit refers to one vascular graft.

  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Transplantation
  • United States
  • Humacyte, Inc.

The prominent features of this report are - ##.

  • Blood Disease
  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Leukemia
  • Novartis AG

## ## ## ## ## ## ## ## Jazz Pharmaceuticals Plc ## ## ## ## ## ## ## ## Takeda Pharmaceutical Co Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Bristol-Myers Squibb Co ## ## ## ## ## ## ## ## AbbVie Inc ## ## ## ## ##

  • General Medicine And Specialty Medicine
  • Lymphoma
  • Transplantation
  • World
  • Product Initiative
  • NUMBER OF PRODUCTS BY STAGE AND MOLECULE TYPE, H2 2018

Following one year of AAT treatment, there will be a one-year follow-up.

  • General Medicine And Specialty Medicine
  • Lung Transplant
  • Therapy
  • Transplantation
  • United States
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Drug Development
  • General Medicine And Specialty Medicine
  • Transplantation
  • World
  • Product Initiative
  • Clinical Trial profile. 549 Trial Title
  • 5. All the trials included are unique trials.

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Takeda Pharmaceutical Company Ltd ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Neopharm Ltd ## ## ## ## ## ## ## ## Mallinckrodt Plc ## ## ## ## ## ## ## ## Bellicum Pharmaceutic

  • Drug Development
  • General Medicine And Specialty Medicine
  • Pharmaceutical
  • Transplantation
  • World

The molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I and Preclinical stages are ##, ##, ##, ## and ## respectively.

  • General Medicine And Specialty Medicine
  • Lung Transplant
  • Transplantation
  • United States
  • Kamada Ltd.
  • Clinical Trial profile. 17 Trial Title
  • CLINICAL TRIAL PROFILE SNAPSHOTS

## ## ## ## Merck & Co Inc ## ## ## ## ## Groupe Francophone des Myelodysplasies ## ## ## ## ## Daiichi Sankyo Co Ltd ## ## ## ## ## CTI BioPharma Corp ## ## ## ## ## Celerion Inc ## ## ## ## ## Bristol-Myers Squibb C

  • Chemotherapy
  • General Medicine And Specialty Medicine
  • Leukemia
  • Therapy
  • Celgene Corporation

The prominent features of this report are - ##.

  • Cancer
  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Leukemia
  • Novartis AG